Our lead product candidate, NGX–4010, is being investigated for its potential to relieve pain by delivering a medication directly to the site of pain. Clinical studies have shown that a single NGX-4010 application to the painful area may provide three months of relief from neuropathic pain, with minimum side effects or drug-drug interactions.